These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10190789)

  • 21. Taxanes in cancer of the head and neck.
    Misiukiewicz K; Gupta V; Bakst R; Posner M
    Anticancer Drugs; 2014 May; 25(5):561-70. PubMed ID: 24534821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase II trial of paclitaxel in squamous cell carcinoma of the head and neck with correlative laboratory studies.
    Smith RE; Thornton DE; Allen J
    Semin Oncol; 1995 Jun; 22(3 Suppl 6):41-6. PubMed ID: 7597432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic chemotherapy with cisplatin plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): efficacy and safety of a lower dose of PF (80/800) at a single institution in Japan.
    Kiyota N; Tahara M; Kadowaki S; Fuse N; Doi T; Minami H; Ohtsu A
    Jpn J Clin Oncol; 2009 Apr; 39(4):225-30. PubMed ID: 19211574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911.
    Langer CJ; Harris J; Horwitz EM; Nicolaou N; Kies M; Curran W; Wong S; Ang K
    J Clin Oncol; 2007 Oct; 25(30):4800-5. PubMed ID: 17947728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Weekly cisplatin paclitaxel and continuous infusion fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma: a phase II study.
    Schena M; Barone C; Birocco N; Dongiovanni D; Numico G; Colantonio I; Bertetto O
    Cancer Chemother Pharmacol; 2005 Mar; 55(3):271-6. PubMed ID: 15592837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy for recurrent and metastatic head and neck cancer.
    Pinto HA; Jacobs C
    Hematol Oncol Clin North Am; 1991 Aug; 5(4):667-86. PubMed ID: 1890059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck.
    Leonard CE; Chan DC; Chou TC; Kumar R; Bunn PA
    Cancer Res; 1996 Nov; 56(22):5198-204. PubMed ID: 8912857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review and outlook for the role of paclitaxel in urothelial carcinoma.
    Vaughn DJ
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):117-22. PubMed ID: 10190793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multimodality therapy of patients with locally advanced squamous cell cancer of the head and neck: preliminary results of two pilot trials using paclitaxel and cisplatin.
    Flood W; Lee DJ; Trotti A; Spencer S; Murphy B; Khuri F; DeConti R; Wheeler R; Forastiere AA
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):64-9. PubMed ID: 10210542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The expanding role of systemic therapy in head and neck cancer.
    Cohen EE; Lingen MW; Vokes EE
    J Clin Oncol; 2004 May; 22(9):1743-52. PubMed ID: 15117998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paclitaxel, cisplatin, 5-fluorouracil and radiotherapy in the management of advanced squamous cell carcinoma of the head and neck: a phase II trial.
    Merlano M; Russi EG; Numico G; Colantonio I; Garrone O; Pelissero A; Granetto C; Gasco M; Di Costanzo G; Heouaine A; Vigna Taglianti R; Cipolat M
    Radiother Oncol; 2005 May; 75(2):193-6. PubMed ID: 16086909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy.
    Argiris A; Li Y; Murphy BA; Langer CJ; Forastiere AA
    J Clin Oncol; 2004 Jan; 22(2):262-8. PubMed ID: 14722034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seven-week continuous-infusion paclitaxel concurrent with radiation therapy for locally advanced non-small cell lung and head and neck cancers.
    Dowell JE; Sinard R; Yardley DA; Aviles V; Machtay M; Weber RS; Weinstein GS; Chalian AA; Carbone DP; Rosenthal DI
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):97-101. PubMed ID: 10210547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paclitaxel: current developmental approaches of the National Cancer Institute.
    Arbuck SG
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):55-63. PubMed ID: 8643972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
    Zanetta G; Fei F; Mangioni C
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carboplatin in combination with raltitrexed in recurrent and metastatic head and neck squamous cell carcinoma: A multicentre phase II study of the Gruppo Oncologico Dell'Italia Meridionale (G.O.I.M.).
    Galetta D; Giotta F; Rosati G; Gebbia V; Manzione L; Di Bisceglie M; Borsellino N; Colucci G
    Anticancer Res; 2005; 25(6C):4445-9. PubMed ID: 16334124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current chemotherapies for recurrent/metastatic head and neck cancer.
    Molin Y; Fayette J
    Anticancer Drugs; 2011 Aug; 22(7):621-5. PubMed ID: 21131821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck.
    Argiris A; Li Y; Forastiere A
    Cancer; 2004 Nov; 101(10):2222-9. PubMed ID: 15452834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.
    Shin DM; Glisson BS; Khuri FR; Lippman SM; Ginsberg L; Diaz E; Papadimitrakopoulou V; Feng L; Francisco M; Garden A; Kies MS; Myers J; Clayman G; Hong WK
    Cancer; 2002 Jul; 95(2):322-30. PubMed ID: 12124833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The current state of adjuvant therapy for breast cancer: focus on paclitaxel.
    Hudis CA
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):1-5. PubMed ID: 10190778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.